Trevi Therapeutics, Inc. · NASDAQ:TRVI

Rubric Capital Management LP reported a 7.12% stake in Trevi Therapeutics, Inc. (Schedule 13G)

Event Jun 30, 2025 · Filed Jul 9, 2025

Rubric Capital Management LP reported a 7.12% stake in Trevi Therapeutics, Inc., 8,531,860 shares, as a passive investor on Jun 30, 2025. Filed Jul 9, 2025 (Schedule 13G).

Stake
7.12%
Shares
8,531,860
Intent
Passive
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
Rubric Capital Management LP7.12%8,531,860
David Rosen7.12%8,531,860

Source

View original at SEC

Related